BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9690708)

  • 1. Olanzapine-induced reversible priaprism: a case report.
    Deirmenjian JM; Erhart SM; Wirshing DA; Spellberg BJ; Wirshing WC
    J Clin Psychopharmacol; 1998 Aug; 18(4):351-3. PubMed ID: 9690708
    [No Abstract]   [Full Text] [Related]  

  • 2. Priapism associated with polypharmacy.
    Seger A; Lamberti JS
    J Clin Psychiatry; 2001 Feb; 62(2):128. PubMed ID: 11247100
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
    Kasper S; Hale A; Azorin JM; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 2():II1-II14. PubMed ID: 10603070
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on "Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders" by Tran and Associates.
    Kasper S; Küfferle B
    J Clin Psychopharmacol; 1998 Aug; 18(4):353-6. PubMed ID: 9690709
    [No Abstract]   [Full Text] [Related]  

  • 6. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effectiveness of antipsychotic drugs.
    Messori A
    Am J Psychiatry; 2003 Mar; 160(3):591-2; author reply 592-3. PubMed ID: 12611854
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Jan; 39(992):5-6. PubMed ID: 9008682
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.
    Tran PV; Hamilton SH; Kuntz AJ; Potvin JH; Andersen SW; Beasley C; Tollefson GD
    J Clin Psychopharmacol; 1997 Oct; 17(5):407-18. PubMed ID: 9315992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priapism following olanzapine administration in a patient with multiple sclerosis.
    Heckers S; Anick D; Boverman JF; Stern TA
    Psychosomatics; 1998; 39(3):288-90. PubMed ID: 9664777
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.
    Aubry JM; Simon AE; Bertschy G
    J Clin Psychiatry; 2000 Sep; 61(9):649-55. PubMed ID: 11030485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine: safe during clozapine-induced agranulocytosis.
    Oyewumi LK; Al-Semaan Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR; Mahmoud R
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
    Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
    J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute dystonia caused by low dosage of olanzapine.
    Alevizos B; Papageorgiou C; Christodoulou GN
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):241. PubMed ID: 12724469
    [No Abstract]   [Full Text] [Related]  

  • 17. Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 1998 Nov; 13(6):253-62. PubMed ID: 9861575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics and cardiovascular risk in schizophrenic patients.
    Bouchard RH; Demers MF; Simoneau I; Alméras N; Villeneuve J; Mottard JP; Cadrin C; Lemieux I; Després JP
    J Clin Psychopharmacol; 2001 Feb; 21(1):110-1. PubMed ID: 11199934
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine-associated priapism.
    Gordon M; de Groot CM
    J Clin Psychopharmacol; 1999 Apr; 19(2):192. PubMed ID: 10211928
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine-associated priapism.
    Childers JB; Schwartz AC; Compton MT
    Psychosomatics; 2003; 44(4):351-2. PubMed ID: 12832606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.